[1] WHO.WHO vaccine position papers[DB/OL].(2020-12-15)[2021-09-02].https://www.who.int/teams/immunization-vaccines-and-biologicals/policies/position-papers.
[2] WHO. Poliomyelitis[DB/OL].(2019-07-22)[2021-09-02].https://www.who.int/news-room/fact-sheets/detail/poliomyelitis.
[3] Global Polio Eradication Initiative. Wild poliovirus list[DB/OL]. (2021-08-31)[2021-09-02].https://polioeradication.org/polio-today/polio-now/wild-poliovirus-list.
[4] WHO. Polio Eradication & endgame STRATEGIC PLAN 2013-2018 executive summary[M]. Geneva: World Health Organization,2013:5-7.
[5] Global Polio Eradication Initiative. circulating vaccine-derived poliovirus[DB/OL].(2021-03-01)[2021-09-02] .https://polioeradication.org/polio-today/polio-now/this-week/circulating-vaccine-derived-poliovirus/.
[6] Luo HM, Zhang Y, Wang XQ, et al.Identification and control of a poliomyelitis outbreak in Xinjiang, China[J].N Engl J Med,2013,369(21):1981-1990.
[7] WHO. Measles: Vaccine preventable diseases surveillance standards [DB/OL]. (2018-10-14)[2021-09-02].https://www.who.int/publications/m/item/vaccine-preventable-diseases-surveillance-standards-measles.
[8] Centers for Disease Control and Prevention. Updated recommendations for isolation of persons with mumps[J].Morb Mortal Wkly,2008,57(40):1103-1105.
[9] WHO. The immunological basis for immunization series: Module 16: Mumps, update2020[DB/OL]. (2020-01-01) [2021-09-02].https://apps.who.int/iris/handle/10665/338004.
[10] Centers for Disease Control and Prevention. Epidemiology and prevention of vaccine-Preventable diseases, 13th edition[M].Washington, D.C.: Public Health Foundation,2015:251.
[11] Marin M, Quinlisk P, Shimabukuro T, et al.Mumps vaccination coverage and vaccine effectiveness in a large outbreak among college students-Iowa,2006[J]. Vaccine,2008,26(29-30):3601-3607.
[12] Donahue M, Hendrickson B, Julian D, et al. Multistate mumps outbreak originating from asymptomatic transmission at a Nebraska Wedding-Six States, August-October2019[J]. Morb Mortal Wkly,2020(69):666-669.
[13] WHO. Technical considerations and case definitions to improve surveillance for viral hepatitis: Technical report[DB/OL].(2016-01-01)[2021-09-02].http://apps.who.int/iris/bitstream/handle/10665/204501/9789241549547_eng.pdf?sequence=1.
[14] Centers for Disease Control and Prevention. Manual for the surveillance of vaccine-preventable diseases[M].Atlanta, GA: Centers for Disease Control and Prevention,2021:136.
[15] WHO. Hepatitis E[DB/OL].(2021-07-27)[2021-09-02]. https://www.who.int/news-room/fact-sheets/detail/hepatitis-e.
[16] WHO.Japanese Encephalitis: Vaccine preventable diseases surveillance standards [DB/OL]. (2018-09-04)[2021-09-02].https://www.who.int/publications/m/item/vaccine-preventable-diseases-surveillance-standards-je.
[17] WHO. The immunological basis for immunization series: Module 4: Pertussis, update2017[DB/OL]. (2017-01-01)[2021-09-02].https://apps.who.int/iris/handle/10665/259388.
[18] Centers for Disease Control and Prevention. Manual for the surveillance of vaccine-preventable diseases[M]. Atlanta, GA: Centers for Disease Control and Prevention, 2021:240-250.
[19] WHO. Pertussis vaccines: WHO position paper[J].Wkly Epidemiol Rec,2015,90(35): 433-58.
[20] 马钰,王安娜,贺晴,等.2020年广州市1起家庭聚集性百日咳疫情流行病学和病原学调查[J]. 中国疫苗和免疫,2021,27(5):528-532.
[21] WHO. Laboratory manual for the diagnosis of whooping cough caused by Bordetella pertussis/ Bordetella parapertussis[M].Geneva: World Health Organization, 2014:7. |
